Comparing the Environmental Costs of Differentiated Service Delivery of Antiretroviral Therapy for People Living with HIV in Rural South Africa
Author(s)
Tseng A1, Szpiro AA1, Heitner J2, van Heerden A3, Ntinga X3, Krows ML1, Schaafsma TT1, Barnabas RV2
1University of Washington, Seattle, WA, USA, 2Massachusetts General Hospital, Boston, MA, USA, 3Human Sciences Research Council, Sweetwaters, KwaZulu-Natal, South Africa
Presentation Documents
OBJECTIVES: We analyzed carbon dioxide (CO2) emissions data to compare the environmental costs of different antiretroviral therapy (ART) refill methods for people living with HIV.
METHODS: Deliver Health Study participants in KwaZulu-Natal, South Africa, were randomized to receive three-month ART refills and monitoring at home or standard clinic-based care. HIV plasma viral load was measured at month 12 exit. We compared cumulative CO2 emissions for quarterly visits over 12 months for participants receiving home vs. clinic-based services. Six- and 12-month refill scenarios were evaluated. We used delivery log data to compute distances from participants’ homes/workplaces to clinics and home delivery routes. Distances were multiplied by estimated CO2 emissions of the transport mode (driving, public transit, or Ford Ranger delivery vehicles), and the cumulative CO2 emissions estimated. The incremental cost-effectiveness ratio was calculated as the change in average CO2 emissions divided by the change in the number of people virally suppressed per group.
RESULTS: Of 154 participants, 83 (54%) were men, the median age was 36 years, and 81 (53%) received home-ART delivery and monitoring. Seventy-one persons were virally suppressed in the home-delivery group compared to 54 in the clinic group. Average cumulative carbon emissions in the home group were 7.25 kilograms of CO2 per person compared to 0.39 kilograms of CO2 in the clinic group. The incremental carbon-cost was 50.16 kilograms of CO2 per person virally suppressed through home delivery, equivalent to driving 271 extra kilometers in the delivery vehicle. If 6- or 12-month refills were provided instead, incremental emissions for home-delivered ART would be 25.08 and 12.54 kilograms of CO2, equivalent to 136 and 68 kilometers driven, respectively.
CONCLUSIONS: In rural South Africa, incremental CO2 emissions were higher for participants receiving home-delivered vs. clinic-based ART refills but could be offset by 6- or 12-month refills and/or changing number of deliveries or vehicle type.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Code
EE180
Topic
Economic Evaluation, Medical Technologies
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis, Implementation Science, Novel & Social Elements of Value
Disease
Infectious Disease (non-vaccine), No Additional Disease & Conditions/Specialized Treatment Areas